BEGIN:VCALENDAR
BEGIN:VEVENT
DTSTART:20090624T153000Z
DTEND:20090624T170000Z
LOCATION:DIA Live Learning Center
DTSTAMP:20090519T212459Z
DESCRIPTION;ENCODING=QUOTED-PRINTABLE:Description: =0D=0AChallenges to instrument development and clinical trial design include meeting the objectives of multiple regulatory authorities. This session will review some of those challenges specific to primary and key secondary endpoints and describe how FDA and EMEA will address some of these issues in an effort to harmonize study endpoint regulatory policy.=0D=0A  For more information please visit the DIA Website at www.diahome.org
SUMMARY:Webinar: FDA and EMEA Efforts to Harmonize Primary Endpoints 
END:VEVENT
END:VCALENDAR